Fujian Cosunter Pharmaceutical Co Ltd (300436) — Capital Reinvestment Ratio

Latest as of December 2024: 0.53x

Fujian Cosunter Pharmaceutical Co Ltd (300436) has a Capital Reinvestment Ratio of 0.53x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥38.14 Million) in capital expenditures (CN¥20.15 Million). See Fujian Cosunter Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.53x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥38.14 Million
CNY

Capital Expenditures

CN¥20.15 Million
CNY

Data as of

Dec 2024
Most recent filing

Fujian Cosunter Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)

This chart tracks Fujian Cosunter Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods.

Annual Capital Reinvestment Ratio for Fujian Cosunter Pharmaceutical Co Ltd (2011–2024)

Year-by-year Capital Reinvestment Ratio for Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see market cap of Fujian Cosunter Pharmaceutical Co Ltd.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 3.23x CN¥20.71 Million CN¥66.99 Million ▼ -7.3%
2020 3.49x CN¥15.60 Million CN¥54.45 Million ▲ +75.0%
2019 2.00x CN¥33.99 Million CN¥67.81 Million ▼ -90.5%
2018 20.95x CN¥10.94 Million CN¥229.26 Million ▲ +4108.5%
2017 0.50x CN¥71.47 Million CN¥35.57 Million ▼ -55.4%
2016 1.12x CN¥73.84 Million CN¥82.50 Million ▲ +290.2%
2015 0.29x CN¥111.63 Million CN¥31.97 Million ▼ -1.3%
2014 0.29x CN¥107.04 Million CN¥31.04 Million ▼ -22.0%
2013 0.37x CN¥66.20 Million CN¥24.61 Million ▼ -40.5%
2012 0.63x CN¥41.97 Million CN¥26.24 Million ▲ +66.4%
2011 0.38x CN¥53.15 Million CN¥19.96 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow